Physician profile
Jonathan Watson
NPI 1285861435
$5,656.69
in general payments reported to CMS, 2019-2025
23 companies · $554 in 2025
The $554 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2021: $1,345 · 2022: $1,639 · 2023: $1,558 · 2024: $338 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,749 · Travel and Lodging: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,748.91 |
| Travel and Lodging | $700.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $2,692.80 | 2021-2023 | |
| Lightbody Medical Technologies INC | $736.94 | 2023-2025 | |
| Electronic Waveform Lab, INC. | $649.60 | 2021-2023 | |
| Stryker Corporation | $356.21 | 2019-2025 | Gamma, Alphavent, System 9 Cd Nxt |
| Arthrex, INC. | $278.08 | 2023 | |
| Zimmer Biomet Holdings, INC. | $192.31 | 2019 | |
| Fidia Pharma USA INC. | $116.48 | 2022-2025 | Hymhyn, Hyalgan, Triluron |
| Depuy Synthes Sales INC. | $111.02 | 2022-2024 | Twistr, Truespan Orthocord, Monovisc |
| Orthofix Medical, INC. | $80.41 | 2021-2025 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $58.64 | 2022-2025 | Zilretta |
| Acumed LLC | $48.04 | 2025 | Acumed |
| Avanos Medical | $46.76 | 2023-2024 | Genvisc 850 Sodium Hyaluronate, Trivisc Sodium Hyaluronate |
| Boston Scientific Corporation | $41.47 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $39.15 | 2025 | |
| Linvatec Corporation | $38.90 | 2023-2025 | Biobrace 23mm, Linvatec Shoulder Arthroscopy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $36.73 | 2021 | |
| Globus Medical, INC. | $24.06 | 2023 | Troch Nail |
| Djo, LLC | $23.47 | 2025 | Cmf |
| Ermi LLC | $20.41 | 2025 | |
| Bioventus LLC | $17.33 | 2025 | Gelsyn-3 |
| Horizon Therapeutics Plc | $16.66 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.89 | 2023 | Seglentis |
| Catalyst Orthoscience | $15.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.